Analysis of alternative promoter usage in expression of HSD11B1 including the development of a transcript-specific quantitative real-time PCR method

Chemico-Biological Interactions

Volumn 191, Issue 1-3, 2011, Pages 104-112

  Staab, Claudia A ^a   Stegk, Jochen P ^a   Haenisch, Sierk ^a   Neiß, Elisabeth ^a   Köbsch, Katrin ^a   Ebert, Bettina ^a   Cascorbi, Ingolf ^a   Maser, Edmund ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

11 Hydroxysteroid dehydrogenase type 1; Gene regulation; Promoter usage; Real time PCR

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GLUCOCORTICOID; PROTEIN P2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR P1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CONFERENCE PAPER; CONTROLLED STUDY; FLUORESCENCE; GENE EXPRESSION; GENE PROBE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LUNG; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; UPREGULATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 3T3-L1 CELLS; 5' UNTRANSLATED REGIONS; ADULT; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FLUORESCENT DYES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; HUMANS; LIVER; LUNG; MALE; MICE; MYOBLASTS, SKELETAL; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SUBCUTANEOUS FAT; TIME FACTORS;

EID: 79957562818     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.12.027     Document Type: Conference Paper

References (41)

1. S. Nomura, M. Fujitaka, N. Sakura, K. Ueda, Circadian rhythms in plasma cortisone and cortisol and the cortisone/cortisol ratio, Clin. Chim. Acta 266 (1997) 83-91.
2. C.A. Staab, E. Maser, 11β-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation, J. Steroid Biochem.Mol. Biol. 119 (2010) 56-72.
3. J.B. Smith, G. Nolan, W. Jubiz, The relationship between unbound and total cortisol: its usefulness in detecting CBG abnormalities, Clin. Chim. Acta 108 (1980) 435-445.
4. V. Gayrard, M. Alvinerie, P.L. Toutain, Interspecies variations of corticosteroid-binding globulin parameters, Domest. Anim. Endocrinol. 13 (1996) 35-45. (Pubitemid 2617593)
5. B. Persson, Y. Kallberg, J.E. Bray, E. Bruford, S.L. Dellaporta, A.D. Favia, R.G. Duarte, H. Jörnvall, K.L. Kavanagh, N. Kedishvili, M. Kisiela, E. Maser, R. Mindnich, S. Orchard, T.M. Penning, J.M. Thornton, J. Adamski, U. Oppermann, The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative, Chem. Biol. Interact. 178 (2009) 94-98.
6. E. Maser, B. Völker, J. Friebertshäuser, 11β- Hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase, Biochemistry 41 (2002) 2459-2465. (Pubitemid 34160910)
7. A. Blum, E. Maser, Enzymology and molecular biology of glucocorticoid metabolism in humans, Prog. Nucleic Acid Res. Mol. Biol. 75 (2003) 173-216. (Pubitemid 137639558)
8. H. Masuzaki, J. Paterson, H. Shinyama, N.M. Morton, J.J. Mullins, J.R. Seckl, J.S. Flier, A transgenic model of visceral obesity and the metabolic syndrome, Science 294 (2001) 2166-2170. (Pubitemid 33150673)
9. M. Wamil, J.R. Seckl, Inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target, Drug Discov. Today 12 (2007) 504-520. (Pubitemid 47031664)
10. J.P. Stegk, B. Ebert, H.J. Martin, E. Maser, Expression profiles of human 11β-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases, Mol. Cell. Endocrinol. 301 (2009) 104-108.
11. J. Bryndova, S. Zbankova, M. Kment, J. Pacha, Colitis up-regulates local glucocorticoid activation and down-regulates inactivation in colonic tissue, Scand. J. Gastroenterol. 39 (2004) 549-553.
12. P. Ergang, P. Leden, J. Bryndova, S. Zbankova, I. Miksik, M. Kment, J. Pacha, Glucocorticoid availability in colonic inflammation of rat, Dig. Dis. Sci. 53 (2008) 2160-2167.
13. M.S. Cooper, E.H. Rabbitt, P.E. Goddard, W.A. Bartlett, M. Hewison, P.M. Stewart, Osteoblastic 11β-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure, J. Bone Miner. Res. 17 (2002) 979-986.
14. A. Hermanowski-Vosatka, J.M. Balkovec, K. Cheng, H.Y. Chen, M. Hernandez, G.C. Koo, C.B. Le Grand, Z. Li, J.M. Metzger, S.S. Mundt, H. Noonan, C.N. Nunes, S.H. Olson, B. Pikounis, N. Ren, N. Robertson, J.M. Schaeffer, K. Shah, M.S. Springer, A.M. Strack, M. Strowski, K. Wu, T.Wu, J. Xiao, B.B. Zhang, S.D. Wright, R. Thieringer, 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice, J. Exp. Med. 202 (2005) 517-527.
15. E. Maser, U.C. Oppermann, Role of type-1 11β-hydroxysteroid dehydrogenase in detoxification processes, Eur. J. Biochem. 249 (1997) 365-369.
16. E. Maser, E. Richter, J. Friebertshauser, The identification of 11β-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, Eur. J. Biochem. 238 (1996) 484-489.
17. E. Maser, J. Friebertshauser, B. Volker, Purification, characterization and NNK carbonyl reductase activities of 11β-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen, Chem. Biol. Interact. 143-144 (2003) 435-448.
18. E. Maser, Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? Trends Pharmacol. Sci. 18 (1997) 270-275. (Pubitemid 27353244)
19. E. Maser, Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK, Trends Pharmacol. Sci. 25 (2004) 235-237.
20. M. Soldan, G. Nagel, M. Losekam, M. Ernst, E. Maser, Interindividual variability in the expression and NNK carbonyl reductase activity of 11β-hydroxysteroid dehydrogenase 1 in human lung, Cancer Lett. 145 (1999) 49-56. (Pubitemid 29459069)
21. J.W. Tomlinson, E.A. Walker, I.J. Bujalska, N. Draper, G.G. Lavery, M.S. Cooper, M. Hewison, P.M. Stewart, 11β-hydroxysteroid dehydrogenase type 1: a tissuespecific regulator of glucocorticoid response, Endocr. Rev. 25 (2004) 831-866.
22. C. Bruley, V. Lyons, A.G. Worsley, M.D. Wilde, G.D. Darlington, N.M.Morton, J.R. Seckl, K.E. Chapman, A novel promoter for the 11β-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPα independent, Endocrinology 147 (2006) 2879-2885. (Pubitemid 43778692)
23. I. Rogatsky, J.M. Trowbridge, M.J. Garabedian, Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms, Mol. Cell. Biol. 17 (1997) 3181-3193. (Pubitemid 27215033)
24. K.L. King, J.A. Cidlowski, Cell cycle regulation and apoptosis, Annu. Rev. Physiol. 60 (1998) 601-617. (Pubitemid 28157888)
25. M.K. Samuelsson, A. Pazirandeh, B. Davani, S. Okret, p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells, Mol. Endocrinol. 13 (1999) 1811-1822. (Pubitemid 30645255)
26. L.R. Viegas, E. Hoijman, M. Beato, A. Pecci, Mechanisms involved in tissuespecific apopotosis regulated by glucocorticoids, J. Steroid Biochem. Mol. Biol. 109 (2008) 273-278.
27. E.H. Rabbitt, G.G. Lavery, E.A. Walker, M.S. Cooper, P.M. Stewart, M. Hewison, Prereceptor regulation of glucocorticoid action by 11β- hydroxysteroid dehydrogenase: a novel determinant of cell proliferation, FASEB J. 16 (2002) 36-44. (Pubitemid 34027948)
28. R. Thieringer, C.B. Le Grand, L. Carbin, T.Q. Cai, B. Wong, S.D. Wright, A. Hermanowski-Vosatka, 11β-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages, J. Immunol. 167 (2001) 30-35. (Pubitemid 32567757)
29. L. Freeman, M. Hewison, S.V. Hughes, K.N. Evans, D. Hardie, T.K. Means, R. Chakraverty, Expression of 11β-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells, Blood 106 (2005) 2042-2049.
30. F.O. Martinez, S. Gordon, M. Locati, A. Mantovani, Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression, J. Immunol. 177 (2006) 7303-7311. (Pubitemid 44715100)
31. A. Napolitano, M.W. Voice, C.R. Edwards, J.R. Seckl, K.E. Chapman, 11β-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated, J. Steroid Biochem. Mol. Biol. 64 (1998) 251-260. (Pubitemid 28221628)
32. J. Berger, M. Tanen, A. Elbrecht, A. Hermanowski-Vosatka, D.E. Moller, S.D. Wright, R. Thieringer, Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity, J. Biol. Chem. 276 (2001) 12629-12635.
33. Y.S. Cho, C.H. Kim, H.G. Cheon, Cell-based assay for screening 11β-hydroxysteroid dehydrogenase 1 inhibitors, Anal. Biochem. 392 (2009) 110-116.
34. E.H. Rabbitt, N.J. Gittoes, P.M. Stewart, M. Hewison, 11β-hydroxysteroid dehydrogenases, cell proliferation and malignancy, J. Steroid Biochem.Mol. Biol. 85 (2003) 415-421. (Pubitemid 37020891)
35. Z. Yang, C. Guo, P. Zhu, W. Li, L. Myatt, K. Sun, Role of glucocorticoid receptor and CCAAT/enhancer-binding protein α in the feed-forward induction of 11β-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts, J. Endocrinol. 195 (2007) 241-253. (Pubitemid 350143104)
36. S. Sai, C.L. Esteves, V. Kelly, Z. Michailidou, K. Anderson, A.P. Coll, Y. Nakagawa, T. Ohzeki, J.R. Seckl, K.E. Chapman, Glucocorticoid regulation of the promoter of 11β-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-β,Mol. Endocrinol. 22 (2008) 2049-2060.
37. A. Balachandran, H. Guan, M. Sellan, S. van Uum, K. Yang, Insulin and dexamethasone dynamically regulate adipocyte 11β-hydroxysteroid dehydrogenase type 1, Endocrinology 149 (2008) 4069-4079.
38. M.W. Voice, J.R. Seckl, C.R. Edwards, K.E. Chapman, 11β- hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: amodel system for the study of hepatic glucocorticoid metabolism, Biochem. J. 317 (Pt 2) (1996) 621-625.
39. Y. Iwasaki, S. Takayasu, M. Nishiyama, M. Tsugita, T. Taguchi, M. Asai, M. Yoshida, M. Kambayashi, K. Hashimoto, Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11β-hydroxysteroid dehydrogenase type 1) gene, Mol. Cell. Endocrinol. 285 (2008) 10-18.
40. B.M. Spiegelman, H. Green, Control of specific protein biosynthesis during the adipose conversion of 3T3 cells, J. Biol. Chem. 255 (1980) 8811-8818.
41. M. Alexander, G. Curtis, J. Avruch, H.M. Goodman, Insulin regulation of protein biosynthesis in differentiated 3T3 adipocytes. Regulation of glyceraldehyde-3-phosphate dehydrogenase, J. Biol. Chem. 260 (1985) 11978-11985. (Pubitemid 16228353)